DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
BFH772
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BFH772
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DPOC-4088
1
Small molecule
Investigational
Unknown
Unknown
Venous Thrombosis
Unknown
DPOC-4088
×
Maximum Phase:
1
First Approval:
None
UNII:
S6MPG81Y84
Molecule Type:
Small molecule
Molecular Formula:
C19H16ClF3N6O2
Molecular Weight:
452.82
AlogP:
2.35
PSA:
101.8
HBD:
2.0
HBA:
#RotB:
8.0
Source:
AZD-1390
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
Unknown
AZD-1390
×
Maximum Phase:
1
First Approval:
None
UNII:
CI43QFE22O
Molecule Type:
Small molecule
Molecular Formula:
C27H32FN5O2
Molecular Weight:
477.58
AlogP:
4.93
PSA:
65.18
HBD:
0.0
HBA:
#RotB:
7.0
Source:
VK-0214
1
Small molecule
Investigational
Unknown
Unknown
Adrenoleukodystrophy
Unknown
VK-0214
×
Maximum Phase:
1
First Approval:
None
UNII:
6FGG71NJ3Y
Molecule Type:
Small molecule
Molecular Formula:
C23H25O5P
Molecular Weight:
412.42
AlogP:
4.7
PSA:
86.99
HBD:
3.0
HBA:
#RotB:
7.0
Source:
BIFENDATE
1
Small molecule
Investigational
Unknown
Unknown
Fibrosis; Liver Cirrhosis; Liver Diseases
Unknown
BIFENDATE
×
Maximum Phase:
1
First Approval:
None
UNII:
0G32E321W1
Molecule Type:
Small molecule
Molecular Formula:
C20H18O10
Molecular Weight:
418.35
AlogP:
2.4
PSA:
107.98
HBD:
0.0
HBA:
#RotB:
5.0
Source:
JNJ-38877605
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Hepatocyte growth factor receptor inhibitor
JNJ-38877605
×
Maximum Phase:
1
First Approval:
None
UNII:
15UDG410PN
Molecule Type:
Small molecule
Molecular Formula:
C19H13F2N7
Molecular Weight:
377.36
AlogP:
3.21
PSA:
73.79
HBD:
0.0
HBA:
#RotB:
3.0
Source:
MSC-2363318A
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MSC-2363318A
×
Maximum Phase:
1
First Approval:
None
UNII:
0DXG50I4WD
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
D-3263
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Transient receptor potential cation channel subfamily M member 8 agonist
D-3263
×
Maximum Phase:
1
First Approval:
None
UNII:
70FBL3TX3E
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ATUVECICLIB
1
Small molecule
Investigational
Unknown
Unknown
Leukemia
Unknown
ATUVECICLIB
×
Maximum Phase:
1
First Approval:
None
UNII:
63Q7F59W0V
Molecule Type:
Small molecule
Molecular Formula:
C18H18FN5O2S
Molecular Weight:
387.44
AlogP:
3.61
PSA:
100.85
HBD:
2.0
HBA:
#RotB:
6.0
Source:
CR-3465
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Cysteinyl leukotriene receptor 1 antagonist
CR-3465
×
Maximum Phase:
1
First Approval:
None
UNII:
5DC7F7S5N7
Molecule Type:
Small molecule
Molecular Formula:
C29H21FN3NaO4
Molecular Weight:
517.49
AlogP:
4.93
PSA:
101.41
HBD:
2.0
HBA:
#RotB:
8.0
Source:
BDTX189
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BDTX189
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C29H29ClN6O4
Molecular Weight:
561.04
AlogP:
4.84
PSA:
110.73
HBD:
2.0
HBA:
#RotB:
11.0
Source:
VP-14637
1
Small molecule
Investigational
Unknown
Unknown
Respiratory Syncytial Virus Infections
Unknown
VP-14637
×
Maximum Phase:
1
First Approval:
None
UNII:
HCW4G0O030
Molecule Type:
Small molecule
Molecular Formula:
C25H22N10O3
Molecular Weight:
510.52
AlogP:
2.34
PSA:
172.61
HBD:
3.0
HBA:
#RotB:
7.0
Source:
MK-7655
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MK-7655
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ORM-13070
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ORM-13070
×
Maximum Phase:
1
First Approval:
None
UNII:
X676C040B7
Molecule Type:
Small molecule
Molecular Formula:
C20H25N3O3
Molecular Weight:
355.44
AlogP:
2.19
PSA:
47.06
HBD:
0.0
HBA:
#RotB:
5.0
Source:
ABT-102
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Vanilloid receptor antagonist
ABT-102
×
Maximum Phase:
1
First Approval:
None
UNII:
J0YBN3USJN
Molecule Type:
Small molecule
Molecular Formula:
C21H24N4O
Molecular Weight:
348.45
AlogP:
4.67
PSA:
69.81
HBD:
3.0
HBA:
#RotB:
2.0
Source:
OSI-027
1
Small molecule
Investigational
Unknown
Unknown
Lymphedema; Lymphoma
Serine/threonine-protein kinase mTOR inhibitor
OSI-027
×
Maximum Phase:
1
First Approval:
None
UNII:
25MKH1SZ0M
Molecule Type:
Small molecule
Molecular Formula:
C21H22N6O3
Molecular Weight:
406.45
AlogP:
3.22
PSA:
131.42
HBD:
3.0
HBA:
#RotB:
4.0
Source:
ISOAMYL 2-CYANOACRYLATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ISOAMYL 2-CYANOACRYLATE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
L-778123
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma
Unknown
L-778123
×
Maximum Phase:
1
First Approval:
None
UNII:
2A2059P49U
Molecule Type:
Small molecule
Molecular Formula:
C22H20ClN5O
Molecular Weight:
405.89
AlogP:
3.31
PSA:
65.16
HBD:
0.0
HBA:
#RotB:
5.0
Source:
ME-344
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Colorectal Neoplasms; Neoplasms
Mitochondrial complex I (NADH dehydrogenase) inhibitor
ME-344
×
Maximum Phase:
1
First Approval:
None
UNII:
843G0TDV51
Molecule Type:
Small molecule
Molecular Formula:
C22H20O4
Molecular Weight:
348.4
AlogP:
4.42
PSA:
69.92
HBD:
3.0
HBA:
#RotB:
2.0
Source:
RG-7304
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RG-7304
×
Maximum Phase:
1
First Approval:
None
UNII:
D0D4252V97
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZD-4573
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AZD-4573
×
Maximum Phase:
1
First Approval:
None
UNII:
E5XSP3X68B
Molecule Type:
Small molecule
Molecular Formula:
C22H28ClN5O2
Molecular Weight:
429.95
AlogP:
3.81
PSA:
88.91
HBD:
2.0
HBA:
#RotB:
4.0
Source:
2MD
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
2MD
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
5-AMINOVALERIC ACID
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
5-AMINOVALERIC ACID
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C5H11NO2
Molecular Weight:
117.15
AlogP:
0.2
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
4.0
Source:
ZIDEBACTAM
1
Small molecule
Investigational
Unknown
Unknown
Bacterial Infections
Unknown
ZIDEBACTAM
×
Maximum Phase:
1
First Approval:
None
UNII:
YPM97423DB
Molecule Type:
Small molecule
Molecular Formula:
C13H21N5O7S
Molecular Weight:
391.41
AlogP:
-1.86
PSA:
157.38
HBD:
4.0
HBA:
#RotB:
4.0
Source:
S-3304
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Neoplasms
Unknown
S-3304
×
Maximum Phase:
1
First Approval:
None
UNII:
BK459F050X
Molecule Type:
Small molecule
Molecular Formula:
C24H20N2O4S2
Molecular Weight:
464.57
AlogP:
3.91
PSA:
99.26
HBD:
3.0
HBA:
#RotB:
6.0
Source:
PF-04620110
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2; Obesity
Unknown
PF-04620110
×
Maximum Phase:
1
First Approval:
None
UNII:
CQ4M18RLJW
Molecule Type:
Small molecule
Molecular Formula:
C21H24N4O4
Molecular Weight:
396.45
AlogP:
2.85
PSA:
118.64
HBD:
2.0
HBA:
#RotB:
4.0
Source:
LY404039
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Metabotropic glutamate receptor 2 agonist
LY404039
×
Maximum Phase:
1
First Approval:
None
UNII:
531QUG7P9E
Molecule Type:
Small molecule
Molecular Formula:
C7H9NO6S
Molecular Weight:
235.22
AlogP:
-2.1
PSA:
134.76
HBD:
3.0
HBA:
#RotB:
2.0
Source:
TUCARESOL
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
TUCARESOL
×
Maximum Phase:
1
First Approval:
None
UNII:
JH368G5B9M
Molecule Type:
Small molecule
Molecular Formula:
C15H12O5
Molecular Weight:
272.26
AlogP:
2.48
PSA:
83.83
HBD:
2.0
HBA:
#RotB:
5.0
Source:
OLOCROLIMUS
1
Small molecule
Investigational
Unknown
Unknown
Unknown
FK506-binding protein 1A inhibitor
OLOCROLIMUS
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MIP-1095 I-123
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MIP-1095 I-123
×
Maximum Phase:
1
First Approval:
None
UNII:
HD4940602J
Molecule Type:
Small molecule
Molecular Formula:
C19H25IN4O8
Molecular Weight:
560.33
AlogP:
1.65
PSA:
194.16
HBD:
7.0
HBA:
#RotB:
13.0
Source:
GMI-1271
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GMI-1271
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TTP-607
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Neoplasms
Serine/threonine-protein kinase Aurora inhibitor
TTP-607
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ONAPRISTONE
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Neoplasms; Prostatic Neoplasms
Progesterone receptor antagonist
ONAPRISTONE
×
Maximum Phase:
1
First Approval:
None
UNII:
H6H7G23O3N
Molecule Type:
Small molecule
Molecular Formula:
C29H39NO3
Molecular Weight:
449.64
AlogP:
5.16
PSA:
60.77
HBD:
2.0
HBA:
#RotB:
5.0
Source:
2,3-DIMERCAPTO-1-PROPANESULFONIC ACID
1
Small molecule
Investigational
Unknown
Unknown
Hepatolenticular Degeneration
Unknown
2,3-DIMERCAPTO-1-PROPANESULFONIC ACID
×
Maximum Phase:
1
First Approval:
None
UNII:
086L82361J
Molecule Type:
Small molecule
Molecular Formula:
C3H8O3S3
Molecular Weight:
188.29
AlogP:
0.1
PSA:
54.37
HBD:
3.0
HBA:
#RotB:
3.0
Source:
HSD-016
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
HSD-016
×
Maximum Phase:
1
First Approval:
None
UNII:
C4I13768E1
Molecule Type:
Small molecule
Molecular Formula:
C21H21F7N2O3S
Molecular Weight:
514.46
AlogP:
4.51
PSA:
60.85
HBD:
1.0
HBA:
#RotB:
4.0
Source:
1
2
…
59
60
61
62
63
64
65
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA